(Q54274795)

27 May 2018

title

TNF impairs in vivo and in vitro natural killer (NK) susceptibility of B16 melanoma cells. (English)

1 reference

27 May 2018

0 references

3

1 reference

27 May 2018

author name string

Palmieri G

1

1 reference

27 May 2018

Morrone S

2

1 reference

27 May 2018

De Giovanni C

4

1 reference

27 May 2018

Nicoletti G

5

1 reference

27 May 2018

Nanni P

6

1 reference

27 May 2018

Frati L

7

1 reference

27 May 2018

Santoni A

8

1 reference

27 May 2018

publication date

1 March 1992

1 reference

27 May 2018

Scandinavian Journal of Immunology

published in

1 reference

27 May 2018

volume

35

1 reference

27 May 2018

issue

3

1 reference

27 May 2018

page(s)

279-287

1 reference

27 May 2018

Cachectin and tumour necrosis factor as two sides of the same biological coin

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1992.TB02860.X

Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1992.TB02860.X

Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1992.TB02860.X

Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1992.TB02860.X

Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1992.TB02860.X

Lymphokine-activated killer cell activity Characteristics of effector cells and their progenitors in blood and spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1992.TB02860.X

Interferon-mediated enhancement of metastasis. Are MHC antigens involved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1992.TB02860.X

Interferon is able to reduce tumor cell susceptibility to human lymphokine-activated killer (LAK) cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1992.TB02860.X

Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1992.TB02860.X

Tumor necrosis factor and immune interferon act in concert to slow the lateral diffusion of proteins and lipids in human endothelial cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1992.TB02860.X

Three distinct classes of regulatory cytokines control endothelial cell MHC antigen expression. Interactions with immune gamma interferon differentiate the effects of tumor necrosis factor and lymphotoxin from those of leukocyte alpha and fibroblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1992.TB02860.X

Interleukin-1 alpha and tumor necrosis factor-alpha protect cells against natural killer cell-mediated cytotoxicity and natural killer cytotoxic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1992.TB02860.X

Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1992.TB02860.X

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1992.TB02860.X

Polypetide mediator network

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1992.TB02860.X

Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1992.TB02860.X

Interleukin-2 augments natural killer cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1992.TB02860.X

HLA class II induction in human islet cells by interferon-γ plus tumour necrosis factor or lymphotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.1992.TB02860.X

10.1111/J.1365-3083.1992.TB02860.X

21 January 2018

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018